Prednisolone Suppresses the Extracellular Release of HMGB-1 and Associated Inflammatory Pathways in Kawasaki Disease
Innate immune activity plays an essential role in the development of Kawasaki disease (KD) vasculitis. Extracellular release of high mobility group box-1 (HMGB-1), an endogenous damage-associated molecular pattern protein that can activate the innate immune system and drive host inflammatory respons...
Main Authors: | Kentaro Ueno, Yuichi Nomura, Yasuko Morita, Yoshifumi Kawano |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-05-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2021.640315/full |
Similar Items
-
Egyptian evidence-based consensus on clinical practice recommendations for the management of Kawasaki disease
by: Yasser El Miedany, et al.
Published: (2023-04-01) -
Audio-vestibular manifestations in Kawasaki disease (KD): a rare atypical case presentation
by: R. Mayuri Rao, et al.
Published: (2022-08-01) -
Aspirin Dose and Treatment Outcomes in Kawasaki Disease: A Historical Control Study in Japan
by: Yu Ito, et al.
Published: (2020-05-01) -
Kawasaki disease following administration of 13-valent pneumococcal conjugate vaccine in young children
by: Yung, Chee Fu, et al.
Published: (2020) -
The differential equation model of pathogenesis of Kawasaki disease with theoretical analysis
by: Rong Qiang, et al.
Published: (2019-04-01)